CD8A and neoplasm: Thus, there is a growing interest in administering ketogenic diets to cancer patients, with the goal of leveraging reduced systemic glucose as a means of inhibiting tumor cell proliferation (38–40), possibly through the induction of oxidative cellular damage and/or increases in cytokine production and cytolysis via tumor-reactive CD8+ T cells (41, 42).